Exploiting the plant secretory pathway to improve the anti-cancer activity of a plant-derived HPV16 E7 vaccine

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 1, 2006, Pages 187-197

  Franconi, R ^a,d   Massa, S ^a   Illiano, E ^a   Muller, A ^b   Cirilli, A ^b   Accardi, L ^c   Di Bonito, P ^c   Giorgi, C ^c   Venuti, A ^b  

^a ENEA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d ENEA C R CASACCIA   (Italy)

Author keywords

Cancer immunotherapy; Human papilloma virus; Plant; Plant signal peptide; Vaccine

Indexed keywords

PROTEIN E7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOGENICITY; MOUSE; NONHUMAN; POTYVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECRETORY VESICLE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; VACCINE PRODUCTION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, VIRAL; BLOTTING, WESTERN; CANCER VACCINES; DNA, PLANT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; IMMUNIZATION; IMMUNOBLOTTING; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TOBACCO; VIRAL VACCINES;

EID: 33646264541     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2:342.
2. Parkin D.M., F. Bray, J. Ferlay and P. Pisani. 2001. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94:153.
3. Tindle W.R. 2002. Immune evasion in human papillomavirus-associated cervical cancer. Nature Rev. Cancer 2:1.
4. Koutsky L.A., K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, F.B. Alvarez, L.M. Chiacchierini and K.U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645.
5. Brinkman J.A., A.S. Caffrey, L.I. Muderspach, L.D. Roman and W.M. Kast. 2005. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. Eur. J. Gynaecol. Oncol. 26:129.
6. Kadish A.S. and M.H. Einstein. 2005. Vaccine strategies for human papillomavirus-associated cancers. Curr. Opin. Oncol. 17:456.
7. Reinstein E., M. Scheffner, M. Oren, A. Ciechanover and A. Schwartz. 2000. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19:5944.
8. Fernando G.J.P., B. Murray, J. Zhou and I.H. Frazer. 1999. Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin. Exp. Immunol. 115:397.
9. Frazer I.H. 2004. Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 4:46.
10. Biemelt S., U. Sonnewald, P. Galmbacher, L. Willmitzer and M. Muller. 2003. Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants. J. Virol. 77:9211.
11. Varsani A., A.L. Williamson, R.C. Rose, M. Jaffer, and E.P. Rybicki. 2003. Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch. Virol. 148:1771.
12. Warzecha H., H.S. Mason, C. Lane, C. Tryggvesson, E. Rybicki, AL. Williamson, J.D. Clements and R.C. Rose. 2003. Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol. 77:8702.
13. Tacket C.O., H.S. Mason, G. Losonsky, J.D. Clements, M.M. Levine and C.J. Arntzen. 1998. Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato. Nat. Med. 4:607.
14. Tacket C.O., H.S. Mason, G. Losonsky, M.K. Estes, M.M. Levine and C.J. Arntzen. 2000. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potato. J. Infect. Dis. 182:302.
15. Thanavala Y., M. Mahoney, S. Pal, A. Scott, L. Richter, N. Natarajan, P. Goodwin, C.J. Arntzen and H.S. Mason. 2005. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. U S A. 102:3378.
16. Tacket C.O., M.F. Pasetti, R. Edelman, J.A. Howard and S. Streatfield. 2004. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22:4385.
17. Canizares M.C., L. Nicholson, and G.P. Lomonossoff. 2005. Use of viral vectors for vaccine production in plants. Immunol. Cell Biol. 83:263.
18. Franconi R., P. Di Bonito, F. Dibello, L. Accardi, A. Muller, A. Birilli, P. Simeone, G. Donà, A. Venuti and C. Giorgi. 2002. Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Research 62:3654.
19. Toubart P., A. Desiderio, G. Salvi, F. Cervone, L. Daroda, G. De Lorenzo, C. Bergmann, A.G. Darvill and P. Albersheim. 1992. Cloning and characterisation of the gene encoding the endopolygalacturonase-inhibiting protein (PGIP) of Phaseoulus vulgaris L. Plant J. 2:367.
20. Franconi R, P. Roggero, P. Pirazzi, F.J. Arias, A. Desiderio, O. Bitti, D. Pashkoulov, B. Mattei, L. Bracci, V. Masenga, R.G. Milne and Benvenuto E. 1999. Functional expression in bacteria and in plants of a scFv antibody fragment against tospoviruses. Immunotechnology 4:189.
21. Di Lonardo A., M.L. Marcante, F. Poggiali and A. Venuti. 1998. HPV16 E7 antibody levels in cervical cancer patients: before and after treatment. J. Med. Virol. 54:192.
22. Miyahira Y., K. Murata, D. Rodriguez, J.R. Rodriguez, M. Esteban, M.M. Rodrigues and F. Zavala. 1995. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol Methods. 181:45.
23. Feltkamp M.C., H.L. Smits, M.P. Vierboom, R.P. Minnaar, B.M. de Jongh, J.W. Drijfhout, J. ter Schegget, C.J. Melief and W.M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J. Immunol. 23:2242.
24. Awram P., R.C. Gardner, R.L. Forster and A.R. Bellamy. 2002. The potential of plant viral vectors and transgenic plants for subunit vaccine production. Adv. Virus Res. 58: 81.
25. Chapman S., T. Kavanagh and D. Baulcombe 1992. Potato virus X as a vector for gene expression in plants. Plant J. 2:549.
26. Pijpers F., R. Faint and N. Saini. 2005. Therapeutic cancer vaccines. Nat. Rev. Drug Discov. 4:623.
27. Twyman R.M., E. Stoger, S. Schillberg, P. Christou and R. Fischer. 2003. Molecular farming in plants: host systems and expression technology. Trends Biotechnol. 21:570.
28. Fischer R., E. Stoger, S. Schillberg, P. Christou and R.M. Twyman. 2004. Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7:152.
29. McCormick A.A., M.H. Kumagai, K. Hanley, T.H. Turpen, I. Hakim, L.K. Grill, D. Tusè, S. Levy and R. Levy. 1999. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc. Natl. Acad. Sci. 96:703.
30. McCormick A.A., S.J. Reinl, T.I. Cameron, F.Vojdani, M. Fronefield, R. Levy and D. Tusè. 2003. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J. Immunol Methods 278:95.
31. Verch T., V. Yusibov and H. Koprowski. 1998. Expression and assembly of a full-length monoclonal antibody in plants using a plant-virus vector. J. Immunol. Meth. 220:69.
32. Verch T., D.C. Hooper, A. Kiyatkin, Z. Steplewski and H. Koprowski. 2004. Immunization with a plant-produced colorectal cancer antigen. Cancer Immunol. Immunother. 53:92.
33. Fernando G.J., T.J. Stewart, R.W. Tindle and I.H. Frazer. 1998. Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scand. J. Immunol. 47:459.
34. Schillberg S., S. Zimmermann, A. Voss and R. Fischer. 1999. Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res. 8:255.
35. Roggero P., M. Ciuffo, E. Benvenuto and R. Franconi. 2001. The expression of a single-chain Fv antibody fragment in different plant hosts and tissues by using potato virus X as a vector. Protein Expres. Purif. 22:70.
36. Stewart T.J., M.J. Smyth, G.J. Fernando, I.H. Frazer and G.R. Leggatt. 2003. Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells. Cancer Res. 63:3058.